The mythology of bold, preemptive (and cheap) intervention against avian flu has been invaluable to the cause of rich countries, like the U.S. and Britain, which prefer to invest in their own biological Maginot Lines, rather than dramatically increase aid to epidemic frontlines overseas—as well as to Big Pharma, which has battled Third World demands for the generic, public manufacture of critical antivirals like Roche’s Tamiflu.
Source: m-x
